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Aequorinrt was initially considered important only in buffering of cytosolic Ca2+ by acting
as a “sink” under conditions of Ca2+ overload. The main regulator of ATP production was considered to be the
relative concentrations of high energy phosphates. However, work by Denton and McCormack in the 1970s
and 1980s showed that free intramitochondrial Ca2+ ([Ca2+]m) activated dehydrogenase enzymes in
mitochondria, leading to increased NADH and hence ATP production. This leads them to propose a scheme,
subsequently termed a “parallel activation model” whereby increases in energy demand, such as hormonal
stimulation or increased workload in muscle, produced an increase in cytosolic [Ca2+] that was relayed by the
mitochondrial Ca2+ transporters into the matrix to give an increase in [Ca2+]m. This then stimulated energy
production to meet the increased energy demand. With the development of methods for measuring [Ca2+]m
in living cells that proved [Ca2+]m changed over a dynamic physiological range rather than simply soaking up
excess cytosolic [Ca2+], this model has now gained widespread acceptance. However, work by ourselves and
others using targeted probes to measure changes in both [Ca2+] and [ATP] in different cell compartments has
revealed variations in the interrelationships between these two in different tissues, suggesting that metabolic
regulation by Ca2+ is ﬁnely tuned to the demands and function of the individual organ.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Ca2+ has been recognised as a potential regulator of metabolism
for 50 years, since Krebs discovered that it activated phosphorylase
kinase in 1959 [1–3]. Mitochondriawere initially considered as “Ca2+-
sinks”, having the ability to take up large amounts of Ca2+, thought to
occur only under conditions of cytosolic Ca2+-overload (for a
historical account see review by Carafoli [4]). Subsequently in the
1960s and 70s, Ca2+ at physiological concentrations was found to
regulate dehydrogenase enzymes of mitochondria: glycerophosphate
dehydrogenase [5], responsible for shuttling reducing equivalents
from cytosolic NADH intomitochondria, and themitochondrial matrix
dehydrogenases pyruvate dehydrogenase (PDH) [6], isocitrate dehy-
drogenase (ICDH)[7] and oxoglutarate (or α-ketoglutarate) dehydro-
genase (OGDH) [8]. Thus Ca2+ stimulates both glycogen breakdown
and glucose oxidation leading to increased ATP supply.
Ca2+ uptake and efﬂux in mitochondria were identiﬁed as separate
pathways (reviewed in [4]), but theywere considered to be important in
regulating cytosolic [Ca2+] ([Ca2+]c), and therefore in regulating
metabolic processes in the cytoplasm [9]. However, work by Richardy, School of Medical Sciences,
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activated dehydrogenase enzymes in mitochondria lead them to
propose a scheme whereby increases in [Ca2+]c were relayed to the
mitochondria resulting in activation of mitochondrial dehydrogenases
and stimulationofATP synthesis (reviewed inMcCormack et al. [10], and
see chapter by Denton in this volume). This “parallel activation model”
provides a mechanism whereby Ca2+ stimulates energy-consuming
processes induced by various hormones, muscle contraction, or
increased workload in the heart, but also provides the means whereby
cells are able to increase ATP supply to keep pace with this increased
demand. Previous measurements of total [Ca2+] in mitochondria gave
high values, in the mM range. However, later methods (see below)
revealed that the free intramitochondrial [Ca2+] ([Ca2+]m) is in the
nM–μM range, which is in the same range as that for activating
dehydrogenases, and similar to free [Ca2+]c. Thus the role of the
mitochondrial Ca2+ transporters under physiological conditions is to
regulate intramitochondrial [Ca2+], and not simply to buffer cytosolic
[Ca2+] [11].
This idea was slowly accepted in the ﬁeld, and the whole area of
mitochondrial Ca2+ signalling gained a resurgence of interest with
the development, in 1992 of a technique for measuring [Ca2+]m
using the photoprotein aequorin targeted to mitochondria [12]. This,
together with the prior development of ﬂuorescent indicators [13]
and more recently genetically encoded ﬂuorescent probes [14],
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role of [Ca2+]m as a regulator of metabolism, but also its role in
controlling whole-cell Ca2+-signalling (see other chapters in this
volume). These techniques, together with those for measuring
[ATP]m and [ATP]c using targeted luciferase[15–17], have revealed
more about the relationship of Ca2+ regulation of mitochondrial ATP
production.
In this chapter we will focus speciﬁcally on the role of [Ca2+]m in
regulating ATP production by mitochondria under physiological
conditions, and the interrelationships of Ca2+, NAD(P)H and ATP in
different cell types, particularly the heart. What seems apparent is
that although similar mechanisms operate in different tissues,
spatial organisation of mitochondria and temporal variations in
ATP, [Ca2+]m and redox state of the cells is different in different cell
types, suggesting that although the control mechanisms are similar,
there are variations in their interrelationships in different tissues.
We will not discuss the role of Ca2+ and the mitochondrial
permeability transition pore (MPTP) in cell death due to either
necrosis or apoptosis, referring the reader to other reviews in this
issue and elsewhere [18–22].
2. Regulation of ATP synthesis in mitochondria
2.1. Early work
Oxidative phosphorylation is the process whereby fuel oxidation
leads to generation of ATP by the mitochondria: Fuel catabolism
produces NADH and FADH2 via mitochondrial dehydrogenases; these
transfer electrons ultimately to oxygen via the electron transport
chain. The energy of electron transfer is utilised to pump protons out
of the mitochondria, creating a pH gradient and membrane potential,
together known as the proton-motive force. This drives protons
through the ATP synthase back into the mitochondria, resulting in
formation of ATP. Transfer of ATP out of mitochondria is via the
adenine nucleotide exchanger. Below is the overall reaction, although
estimates of the number of ATPmolecules synthesised per molecule of
NADH vary:
NADH+H+ +O2 +2:5 ADP+2:5 Pi→NAD
+ +H2O+2:5 ATP:
Oxidative phosphorylation in mitochondria provides most of the
ATP in nearly all cell types, and accounts for over 90% of ATP
production in the heart [23]. It can potentially be regulated by
several different mechanisms; from the equation above, increases
in NADH/NAD+ and ADP/ATP would be expected to increase drive
the forward reaction. Oxygen is not rate limiting until levels below
about 20 μM [10], a level much lower than that occurring
physiologically. Thus it was originally proposed that changes in
the ADP/ATP ratio were the main regulator of ATP synthesis [24],
and this was easily demonstrated in isolated mitochondria.
However, the role of a drop in ATP and increase in ADP as the
trigger for stimulating ATP synthesis in vivo had to be re-evaluated
when studies started demonstrating that high energy phosphate
levels did not change under conditions that imposed a large energy
demand on a tissue, and hence would be expected to produce a
drop in ATP. For example in studies on whole beating hearts using
NMR found ATP, Pi, phosphocreatine levels to remain remarkably
constant, even under conditions where oxygen consumption
increased approximately 3-fold [25,26]. ADP could not be measured
directly, but calculated levels using the creatine kinase equilibrium
indicated that it did not change either [26]. The free [ADP] in
beating hearts was calculated to be around 50 μM [26], which
represents an average value from the whole heart. To achieve the
observed increase in respiration, of 2.5-fold, when the hearts were
stimulated with adrenaline, Katz et al. [26] estimated that [ADP]
would have to increase by about 4-fold, and this was not observedin any of their experiments. This suggested that other factor(s) had
to be involved.
2.2. Activation of dehydrogenases by Ca2+
Of course there had to be an increase in ATP productionwhen cells
and tissues were stimulated, but it seemed that the process was very
ﬁnely tuned, so that ATP supply was almost exactly matched to ATP
utilisation. Work by Denton and others on Ca2+ regulation of
mitochondrial dehydrogenases leads them to propose that an increase
in [Ca2+]m, resulting from a rise in [Ca2+]c that occurred upon
increased workload or agonist stimulation, increases NADH supply
and hence ATP synthesis; thus providing the link between energy
supply and demand (see review by Denton in this issue).
Although this elegant theory is now widely accepted, it met with
resistance at the time, partly due to lack of direct methods for
measuring [Ca2+]m in vivo and of demonstrating that this was in a
range capable of stimulating dehydrogenase activity. However,
McCormack and colleagues had found that activation of PDH occurred
in whole hearts upon inotropic stimulation [27,28], and that this was
prevented by ruthenium red (RuR) [29,30], although there are
problems with using this (see below): “These results provide further
evidence that the activation of PDH by positive inotropes is
accomplished by, and at least in part due to, raised mitochondrial
matrix free [Ca2+] and that such increases can be maintained in
isolated and suitably incubated mitochondria” [31].
2.3. ATP synthase
Several studies have suggested that dual control by Ca2+ may exist
at the level of the dehydrogenases (described above) and the ATP
synthase [23,32,33]. Attempts to correlate the rate of ATP synthesis
with the levels of phosphates, NADH or ΔμH+ in the heart have failed
(reviewed by Balaban [34]), indicating that the ATP synthase cannot
simply be responding to changes in levels of its substrates. For
example; electrical stimulation of adult rat cardiomyocytes leads to
approximately doubling of ATP synthase capacity in 1–2 min, but this
was abolished in the presence of RuR [32]. Territo et al. [33] suggested
a direct activation of the ATPase by Ca2+ with a Km of 200 nM, well
within the physiological range. But as yet there is no mechanism as to
how Ca2+ activates the ATPase, although involvement of speciﬁc Ca2
+-binding proteins that then regulate the ATPase has been proposed
[35,36].
2.4. Mitochondrial Ca2+ transport pathways and overview of regulation
Work on isolated mitochondria suggested that the mitochondrial
Ca2+-uniporter (CaUP), was a relatively slow Ca2+-uptake pathway
because of its low afﬁnity for Ca2+, and the efﬂux pathway, the Na+/
Ca2+-exchanger (mNCX), even slower [37,38] (see review by Sheu
and Gunter in this issue). Later work in the 1990s revealed that the
slow transport by the CaUP could be overcome by having mitochon-
dria situated near Ca2+ release channels of the endoplasmic
reticulum (ER), where they would be exposed to microdomains of
high Ca2+ allowing rapid mitochondrial uptake (reviewed by Rizzuto
in this volume). Fig. 1 gives an overview of the role of [Ca2+]m in
regulating ATP supply and demand.
3. Relationship between mitochondrial [Ca2+], NADP(P)H and
[ATP] in living cells and tissues
3.1. Heart
3.1.1. Mitochondrial Ca2+ measurements in the heart
A question that remained unanswered for some time, and is still
controversial, is whether or not [Ca2+]m changes on a beat-to-beat
Fig. 1. Mitochondrial Ca2+ — key role in regulation of energy supply and demand.
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about 50–150 nM at rest (during diastole) to about 500–2000 nM at
the peak of contraction, or upon stimulation with an agonists or
increased workload. Based on work in isolated mitochondria, the
CaUP and mNCX pathways could certainly not respond quickly
enough to the very rapid (millisecond) changes in [Ca2+]c that
occur during excitation-contraction (EC) coupling. However, more
recent work using isolated myocytes has suggested that mitochon-
drial Ca2+ transients do occur during EC coupling in neonatal and
adult cardiac myocytes [39–41], although there is conﬂicting data on
this in the literature since other studies reported that mitochondrial
Ca2+ accumulation occurred over tens of seconds in cardiac
myocytes [42–44]. Part of the conﬂict may be due to different
species or stage of development (neonate versus adult), however
these equally represent an explanation for the differences although
the implications for having mitochondrial Ca2+ spiking in some
species but not others then present a different question.
Another hurdle has been the lack of speciﬁc inhibitors of the
mitochondrial Ca2+ transporters that can be used in cardiomyo-
cytes. RuR has non-mitochondrial effects, notably on the sarcoplas-
mic reticulum (SR); in isolated myocytes it initially inhibits cell
contraction, but at higher concentrations (above about 10 μM)
causes cytosolic Ca2+ waves and eventual cell hypercontracture
[45], although at these concentrations it does inhibit Ca2+ entry into
mitochondria [42,46]. However, in whole heart studies protective
effects of RuR against myocardial ischaemia/reperfusion injury have
been reported [47,48], and McCormack and England found that
2.5 μg/ml ruthenium red (which would correspond to about 1–
2 μM) could block increases in mitochondrial pyruvate dehydro-
genase activity without altering activation of phosphorylase (a
cytosolic enzyme) upon stimulation of hearts with adrenergic
agonists [29]. Allen et al. [49] pre-perfused isolated rat hearts
with fura-2/AM before induction of hypoxia and reoxygenation and
found 2.5 μM ruthenium red could inhibit the reoxygenation
induced rise in [Ca2+]m; however, no functional effects were
reported and it is possible that this was an indirect result of a
decrease in [Ca2+]c. Why RuR should be more effective in isolated
hearts as opposed to isolated myocytes remains unclear.Ru360 is more speciﬁc for mitochondria than RuR, but we and
others have found that it does not appear to enter either neonatal
[40,41] or adult [41] myocytes. Other groups have, however, reported
success in using Ru360 (see Section 5 below). We have used
clonazepam in adult cardiomyocytes as a relatively speciﬁc inhibitor
of themNCX [50], although in adult guinea-pigmyocytes and neonatal
rat heart cells it inhibited contraction (CJ Bell and EJ Grifﬁths,
unpublished data), and so we could not use it in these cells to probe
mitochondrial function.
3.1.2. NAD(P)H as an indicator of ATP production
Due to the difﬁculty of measuring [ATP] in living cells, NAD(P)H
levels have been used as an indirect indicator of energetic state in
whole hearts [26,51], myocytes [52] or trabeculae [53]. This is done
using cell autoﬂuorescence, so cannot distinguish between NADH and
NADPH, but it has been shown that over 80% of the signal originates
from mitochondria in the heart [54]. It is also important in these
studies to ensure that oxygen supply is not rate limiting, as that would
result in increased NAD(P)H due to inhibition of the respiratory chain
[34]. In well-oxygenated hearts, no change in NAD(P)H was observed
in response to physiological increases in workload [51]. Additionally,
altering the substrate from glucose to pyruvate increased NAD(P)H,
and this was associated with an increase in the ATP/ADP+Pi, and
increases in O2 consumption [55]. However, although lactate gave the
same increase in NAD(P)H, there was no rise in ATP/ADP+Pi. So
similar levels of NAD(P)H were associated with different ATP/ADP
+Pi, and so an increase in NAD(P)H cannot be taken as an
unambiguous indicator of increased ATP production [55].
In myocytes, conﬂicting results have been obtained as to whether
NAD(P)H changes upon rapid stimulation of cells: increases, no
change and decreases have all been reported [43,52,56]. In isolated
trabeculae, NAD(P)H was more carefully measured by using an
internal reference that negated motion artefacts. When the muscle
strips were stimulated at 3 Hz from rest, an initial drop in NAD(P)H
occurred within 5 s, followed by an increase to the initial or higher
levels over 60 s [57]. However, under physiological conditions, the
heart is never likely to be subjected to such a sudden and steep
increase in energy demand (i.e. from rest to beating rapidly). Thus
Fig. 2. Beat-to-beat spikes of mitochondrial Ca2+ in adult and neonatal cardiomyocytes.
[Ca2+]mwas measured using targeted aequorin and calibrated as described in [41]. Both
cell types were exposed to 4 mM external [Ca2+] and isoproterenol. Adult myocytes
were stimulated to contract at 2 Hz; neonatal cells beat spontaneously at about 1 Hz.
Data taken from [41].
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an increase in ATP synthesis.
3.1.3. ATP measurements
In rat hearts, about 2% of cell ATP is consumed with each heart
beat, and under physiological conditions in well-oxygenated hearts,
over 90% of its ATP is made by oxidative phosphorylation [23].
Changes in work rate (ATP utilisation) may be 5–10 fold in vivo, but
ATP levels remain remarkably constant as discussed [25,26] above.
Changes in ATP are initially buffered by the phosphocreatine system:
ADP+phosphocreatine→
creatine kinase
ATP+ creatine:
But this only lasts for a few seconds, so there must be a mechanism
for increasing ATP synthesis rapidly enough to respond to ATP
consumption. Another problem in elucidating the relationship
between [Ca2+]m and [ATP] was that although ATP has beenmeasured
in whole hearts, and now in animals and humans using non-invasive
31P-NMR (reviewed in [34]), only relatively slow responses were
measured, and so it could not be determinedwhether ATPwas varying
beat-to-beat, or during the time taken for mitochondria to accumulate
Ca2+ to a level sufﬁcient to activate the dehydrogenases. In one study
luciferase was microinjected into single cardiomyocytes and rapid
depletion of (cytosolic) ATP levels in response to an uncoupler were
observed [58], but changes in response to physiological conditions, or
in response to normal cell contraction, were not reported. Further-
more, free ATP levels have not been directly measured in different
compartments of the living cardiomyocyte, and the relationship
between mitochondrial [ATP] ([ATPm]) and cytosolic ATP ([ATP]c) is
not known.
3.1.4. Measurement of mitochondrial and cytosolic [Ca2+] and [ATP] in
cardiac myocytes using targeted probes
In a recent paper we expressed aequorin and luciferase in either
mitochondrial or cytosol in adult cardiomyocytes, the ﬁrst time this
has been done [41]. Although it was not possible tomeasure [ATP] and
[Ca2+] simultaneously, we carried out parallel experiments on small
populations of cells under identical conditions where myocytes were
electrically stimulated to contract synchronously. As well as the
expected beat-to-beat changes in [Ca2+]c, we also observed beat-to-
beat changes in [Ca2+]m, the amplitude of which was increased in the
presence of an adrenergic agonist. However, these transients were
only discernible at elevated external [Ca2+]; at lower, physiological
(1–2 mM) external [Ca2+] it was difﬁcult to detect transients, possible
due to the low expression of aequorin in mitochondria compared with
that in the cytosol. Nevertheless, both higher external [Ca2+], and/or
presence of an adrenergic agonists showed clear mitochondrial Ca2+
transients (Fig. 2). In neonatal cells, where mAq was well-expressed,
we observed clear mitochondrial Ca2+ transients even under basal
conditions [41], agreeing with a previous report [40].
We observed no beat-to-beat changes (i.e. N1%) in free [ATP] in
either cytosol or mitochondria using luciferase targeted to these
compartments in adult myocytes [41]. Neither could we observe
changes upon addition of isoproterenol to cells that were already
beating, suggesting that ATP supply is well matched to the increased
demand caused by the isoproterenol-induced increase in contractile
force. Thus [ATP]c was extremely well buffered in myocytes, even
under conditions where the cells were stimulated to beat rapidly in
presence of an adrenergic agonist to further increase ATP demand by
the cell [41]. This is in agreement of studies using whole hearts
described above [51,55].
However, whenwe allowed cells to rest, then suddenly stimulated
to contract in the presence of isoproterenol, [ATP]m showed a
signiﬁcant transient drop (up to 22% in some cells) followed by
recovery to higher than initial levels [41]. These changes seem likely toreﬂect an initial activation of ATP-requiring processes in the cytosol,
such as ion pumps and contractile proteins, which would causes a
drop in [ATP]m before a time-dependent activation of mitochondrial
oxidative metabolism by Ca2+ [16,59] stimulated ATP synthesis. The
changes in [ATP]c were much smaller than those in the mitochondrial
matrix, again suggesting that even when [ATP]m does change, the
cytosolic energy supply is very rapidly matched to the increased
demand.
Since ATP levels are falling, and presumably ADP rising, during the
initial few seconds when cells are stimulated from rest, then ADP
could provide the stimulation of ATP synthesis required to keep [ATP]c
relatively constant during this period. Also, the average [Ca2+]m takes
30–60 s to reach its maximumvalue, and so againwould not stimulate
dehydrogenases and NADH production during the initial phase. Only
after this occurred would [ATP]m increase again. The time courses for
average [Ca2+]m and [ATP]m have been overlaid in Fig. 3 to illustrate
these points.
An important caveat must, however, be made that since we
compared changes in ATP (luciferase) and Ca2+ (aequorin), after one
or two days of culture, respectively, theremay be subtle changes in cell
physiology between these two time points which might affect the
changes in these two parameters following cell stimulation.
This work indicated, for the ﬁrst time that ATP levels in cytosol
and mitochondria respond differently to changes in ATP demand in
these compartments. A possible mechanism for this effect was
suggested by our observation that cardiomyocytes exhibited rapid
Ca2+ pulses during the contractile cycle. These rapid Ca2+ transients
are apparently decoded by the matrix dehydrogenases into a time-
averaged signal that stimulates ATP production to keep pace with
ATP demand, in a manner analogous to the decoding of mitochon-
drial Ca2+ transients in liver [60] and other cell types [61]. Thus,
stimulated mitochondria maintain a constant phosphorylation
potential in the cytosol. This ﬁts with the “parallel activation
model” [34] whereby Ca2+ is the key link — simultaneously
stimulating ATP-consuming processes in the SR, sarcolemma and
Fig. 3. Changes in [ATP]m and average [Ca2+]m in adult cardiomyocytes stimulated to
beat form rest. [Ca2+]m and [ATP]m were measured using targeted aequorin and
luciferase, respectively, in parallel experiments on small populations of cells stimulated
to contract at 2 Hz from rest. In this ﬁgure the average [Ca2+]m is shown, and so
mitochondrial Ca2+ transients are not visible as they are in Fig. 2. Figure modiﬁed form
data ﬁrst published in [41].
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McCormack and Denton [27]. Classical mediators, like ATP, ADP and
Pi would also play a role, as seen in the experiments here where ATP
demand is abruptly increased, and [ATP]m falls, before [Ca2+]m rises
to levels sufﬁcient to activate dehydrogenases.
3.1.5. Importance of subcellular organisation in mitochondrial Ca2+
transport and energy regulation
Studies from many other cell types have indicated that the
subcellular organisation of mitochondria is vital in determining their
Ca2+ handling properties [12,62]. Indeed, Sharma et al. [63] found that
in skinned myocytes application of caffeine to the cells caused a large
release of Ca2+ from the SR that was taken up bymitochondria, as well
as entering the cytosol, and themitochondrial uptakewas inhibited by
RuR. Thus it is conceivable that mitochondria located in close
proximity to Ca2+ channels on the SR or plasma membrane are
exposed to a much higher level of [Ca2+] than those elsewhere in the
cytosol [64], accounting for the ability of at least a subpopulation of
mitochondria to take up Ca2+ on a beat-to-beat basis as we observed
using targeted aequorin [41]. Full discussion of the role of the
mitochondria Ca2+ transporters in modulating whole cell Ca2+
signalling is covered in the article by Sheu and Gunter in this issue,
and recent reviews [65,66].
In addition to the known proximity of mitochondria to the ER in a
variety of cell types, there is now evidence for a direct physical
coupling that persists during isolation of mitochondria (reviewed in
[67]). This evidence was provided in the heart by isolation of
mitochondrial fractions with associated SR components that were
highly resistant to puriﬁcation [64]. These “SR appendices” were
capable of transferring Ca2+ directly to mitochondria (measured with
rhod-2 ﬂuorescence) upon stimulationwith caffeine, and of producing
an increasing in the NADH autoﬂuorescence signal, suggesting
activation of the dehydrogenases. This is the ﬁrst direct evidence
that Ca2+ transfer directly from the SR to mitochondria is capable of
activating oxidative metabolism [64].
As well as being important in mitochondrial Ca2+ dynamics, there
is evidence that the subcellular arrangement of mitochondria with
other cell compartments or enzymes, notably the ATPases, can alsoplay a role in regulating energy metabolism by ADP and ATP. That the
concentration of adenine nucleotide phosphates may differ in regions
around mitochondria was revealed by Saks et al. [68] found that
the apparent Km for exogenous ADP stimulation of respiration at low
[Ca2+] (0–1 μM) was higher in permeabilised cardiomyocytes,
250–350 μM, compared with that in isolated mitochondria, approxi-
mately 20 μM. This and subsequent work led them to propose that
mitochondria are closely associated with structures such as SR and
sarcolemma containing ATPases and are organised into “intracellular
energy units” (ICEUs) [69–71], and they found that cytoskeletal
proteins also played a role in maintaining the structure of the ICEUs
[72]. However, in permeabilised cardiomyocytes exposed to [Ca2+] of
about 1 μM, where the cell underwent contracture and where
mitochondrial [Ca2+]m also rose, there was a marked decrease in
the Km of exogenous ADP for respiration [73], similar to that observed
in isolated mitochondria. The authors concluded from this that
contracture modiﬁed the intracellular structure of the mitochondrial
association with other organelles sufﬁciently to remove the diffusion
limits of ADP seen in the resting cells [73]. Similar evidence for the
existence of ICEUs had been found in skeletal (red) muscle [74].
However, in a non-beating cultured cardiac cell line, where mitochon-
dria are not organised as in adult cardiomyocytes and instead form a
more tubular network seen in many types of non-muscle cell, the Km
of ADP for respiration was similar to that in isolated mitochondria,
indicating absence of ICEUs in these cells[75].
This group also argues that [Ca2+]m may not be the sole factor, or
possibly not a major factor, in regulating ATP supply and demand in
the heart, since modelling studies have predicted that the increase in
[Ca2+]m in the heart would only be enough to stimulate respiration
2–3 fold, whereas increases of 10–20 fold are seen in vivo [33,76,77].
Therefore localised regulation of [ADP] in the ICEUs would present a
method of stimulating ATP synthesis by mitochondria without
changes in bulk [ADP] or [ATP] [73]. However, extrapolating these
studies to the physiological situation of rapidly beating cardiomyo-
cytes, either cells or whole hearts, that are continually shortening and
relengthening is going to be difﬁcult experimentally. If the authors
are correct, the theory also implies that control of respiration by ADP
is operating on a millisecond timescale (in rat cardiomyocytes, for
example). Alternatively respiration could be sensitive to the time-
averaged local [ADP], in a similar manner as we suggested above
for rapid changes in [Ca2+]m. Nevertheless, some evidence for such
gradients of ADP has been provided using NMR combining different
protocols of magnetization transfer and biochemical measurements
[78]; calculated gradients of ADP of 20–100 μM occurred in the
compartment betweenmitochondria, cytosol andmyoﬁbrillar ATPases
[78].
3.2. Other cell types
3.2.1. Overview
In other cell types, regulation of ATP production by [Ca2+]m may
follow a different timecourse, and contribute to a different extent. In
the heart, ATP levels are initially buffered by the phosphocreatine
system, but in other cells such as liver, this is not present and so a fall
in ATP levels may play an important role at least in the early phase of
cell stimulation, although Ca2+ activation of dehydrogenases still
seems to be the dominant factor in maintaining the ATP supply.
3.2.2. HeLa cells
A key paper by Jouaville et al. [79] used aequorin and luciferase
targeted to mitochondria to demonstrate a direct link between [Ca2+]m
and [ATP]m: When HeLa cells were stimulated with histamine, which
releasesCa2+ from intracellular stores via IP3, therewere large increases in
both [Ca2+]mand [ATP]m.Histaminealso causeda transientdrop, followed
by sustained increase, of Δψm. Preventing the rise in [Ca2+]m (using
BAPTA) also prevented rise in [ATP]m, this proving a direct link between
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mechanism: following stimulationwith histamine, [Ca2+]m rose and then
fell again upon histamine washout. Challenging the cells with pyruvate
and lactate following thewashout produced an increase in [ATP]m similar
to that seen in presence of histamine, even though [Ca2+]m had now
returned to basal levels. This was maintained for 30 min after the initial
histamine exposure. The mechanism of this “memory” is unknown, but
possibly involves increases in mitochondrial volume [80], prolonged
changes in Δψm or activation of ATP synthase by Ca2+-binding regulatory
proteins (see above). So there was a strict dependence of [ATP]m on
[Ca2+]m, which can therefore relay changes in cell energy consumption to
the mitochondria.
Since HeLa cells are a cancer cell line and highly glycolytic, the
authors also performed some experiments in skeletal muscle
myotubes, and reached similar conclusions, i.e. that and increase in
[Ca2+]c, this time induced by depolarisation of the myotubes, could
trigger a rise in [ATP]m [79]. A similar phenomenon was observed in a
pancreatic β-cell line that is almost entirely aerobic [81].
3.2.3. Pancreatic islet cells and hypothalamic neurons
Pancreatic islet cells, notably insulin-secreting β and glucagon-
secreting α cells, represent an interesting alternative physiological
paradigm to cardiac and other cells where the role of ATP synthesis
is “purely” to drive ATP consuming process. In these fuel-sensing
neuroendocrine cells, ATP synthesis also plays a central role in signal
transduction by nutrients including glucose. Thus, enhanced mito-
chondrial oxidative activity is required not only to fuel hormone
synthesis, secretory granule trafﬁcking and ﬁnally Ca2+-stimulated
exocytotic release of insulin [82–84], but is also deployed as part of
the machinery by which changes in the plasma concentrations of
glucose and other secretagogues are detected [85,86]. Thus in
pancreatic β cells, the role of Ca2+ in regulating mitochondrial
metabolism is particularly complex and still somewhat controversial
[87]. Here, enhanced glycolytic ﬂux and stimulation of citrate cycle
activity increase cytoplasmic ATP/ADP ratio, leading to closure of
ATP-sensitive K+ (KATP) channels on the plasma membrane [88],
inhibition of AMP-activated protein kinase [89], plasma membrane
depolarisation, and the inﬂux of Ca2+ ions through voltage-sensitive
L-type Ca2+ channels (Cav1.2 and Cav1.3) that then triggers insulin
secretion (reviewed by Rutter [85]). Note that Ca2+-induced Ca2+
release from internal endoplasmic reticulum [90] – or more probably
secretory granule [91] – associated stores may also be involved. This,
in turn, leads to increases in free intramitochondrial Ca2+ concen-
tration, as ﬁrst reported using a mitochondrially-targeted aequorin
[92,93] and more recently with a mitochondrially-targeted GFP-
derived “pericam” (Ravier, M.A. and Rutter, manuscript under
revision), and an apparent increase in mitochondrial and cytosolic
free ATP concentrations as reported with recombinant luciferases
and photon-counting imaging [16,59,94].
Interestingly, both the cytosolic Ca2+ increase [93,95,96] and the
changes in cytosolic and mitochondrial free ATP concentration in
response to elevated glucose concentrations [94] are oscillatory,
matching “slow wave” oscillations in insulin secretion (2–3 min
periodicity). These observations have led to two alternative models
in which either (a) elevated mitochondrial Ca2+ concentrations,
through activating citrate cycle enzymes, the respiratory chain and
ATP synthase [10], leads to elevated ATP delivery to the cytoplasm,
further reinforcing the closure of KATP channels in the plasma
membrane and amplifying Ca2+ inﬂux or (b) that elevated cytosolic
Ca2+drives enhancedATP consumption in this compartment (for Ca2+
extrusion, granule movement etc.) and may lead to a decrease in
mitochondrial proton motive force due to uptake through the
uniporter[97]. Parallel oscillations of intracellular Ca2+ activity and
mitochondrial membrane potential have been observed in mouse
pancreatic β-cells [98]. Arguing for possibility (a), recent studies [99]
in which mitochondrial Ca2+ changes were attenuated by over-expression in the mitochondrial matrix of the Ca2+ binding protein
S100G, diminished glucose-induced increases in mitochondrial
membrane and cytoplasmic ATP concentrations. Hence, in the β cell
system, Ca2+ uptake into mitochondria appears to form part of a feed-
forward loop, which enables mitochondrial ATP synthesis not only to
be enhanced to meet the increased demands for cellular work, but to
further amplify a nutrient-activated signalling mechanism to ensure
normal stimulus-secretion coupling. Whether activation of mitochon-
drial ﬂuxes, for example through the inhibition of the mNCX with
CGP-37157 [100] or by stimulation of PDH activity [38], represent
potential pharmacological targets for the treatment of deﬁcient
insulin secretion in type 2 diabetes, is an interesting possibility.
In pancreatic α cells, elevated glucose concentration leads to
increases in mitochondrial and cytosolic ATP levels though in these
cells coordinated regulation of glucagon release appears to involve
both a direct action and a metabolic action of the sugar [101]. This
possibly involves more minor changes in KATP channel activity [102],
but also signalling from neighbouring β cells via secreted products
such as Zn2+ ions [103] and γ-amino butyric acid (GABA) [104–106].
Finally, glucose-sensitive neurons in themediobasal hypothalamus
associated with the control of feeding, satiety and responses to
hypoglycaemia appear also to engage changes in mitochondrial ATP
synthesis as part of a fuel-sensing system [94,106]. The inter-
relationships between Ca2+ inﬂux, ATP synthesis neuronal ﬁring
and the release of neuropeptides remain to be examined in detail in
this system.
3.2.4 Liver
Liver is a highly metabolically active tissue, with processes such as
gluconeogenesis being regulated by both substrate/product levels as
well as by hormones such as glucagon and vasopressin, the latter
stimulating Ca2+ release from intracellular stores. Studies using
isolated hepatocytes have revealed a complex relationship between
[Ca2+]c, [Ca2+]m and NAD(P)H levels, depending on the amplitude
and duration of the initial change in [Ca2+]c: Hajnoczky et al. [60]
measured [Ca2+]c (using fura-2), NADP(H), and ﬂavoprotein (FAD)
ﬂuorescence simultaneously in single primary hepatocytes. FAD is
predominantly mitochondrial, and since there is an intrinsic FAD-
containing subunit of OGDH and PDH, they used FAD ﬂuorescence as a
direct indicator of dehydrogenase activity.
Upon stimulationwith vasopressin, they observed a spike of [Ca2+]c,
lasting approximately 50 s. The up-phase of the spike triggered a slower
increase in NAD(P)H and decrease of FAD, which took much longer to
return to pre-stimulation values, about 300 s. These [Ca2+]c changes
were transmitted into the mitochondria, which also underwent Ca2+
spiking (measured with rhod-2), over a similar, slightly prolonged,
timescale to the cytosolic spikes. However, with repetitive cytosolic Ca2+
spiking, althoughmitochondrial spikes occur, the NAD(P)H ﬂuorescence
is maintained at an elevated level. Thus indicating that “frequency-
modulated [Ca2+]m signals are translated into a time-averaged redox
response…” [60]. Interestingly, with a sustained, non-oscillatory, rise of
[Ca2+]c, the mitochondrial [Ca2+] declines after the initial rise. They
proposed that this was due to lack of release of Ca2+ from ER stores into
mitochondria. However, theNAD(P)Hdeclinedmore slowly than [Ca2+]m,
suggesting that either there were other factors affecting mitochondrial
metabolism, or that the activity of the dehydrogenases declines more
slowly than [Ca2+]m.
In a subsequent paper, this group assayed PDH synchronously with
NAD(P)H following stimulation of hepatocytes with vasopressin [107].
They observed similar results as before, namely that a prolonged
increase in [Ca2+]c gave rise to a transient increase in [Ca2+]m, the
NAD(P)H signal declining more slowly than [Ca2+]m. PDH activity
increased rapidly, before plateauing brieﬂy followed by a second
sustained increase that persisted even when [Ca2+]m and NAD(P)H
had returned to baseline values [107]. Vasopressin caused a rapid and
sustained decrease in [ATP] by about 15%. They suggested that this
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of PDH activation. However, they reckoned that this would not cause
the second increase in PDH activity, since ATP levels plateaued, rather
the fall in NAD(P)H would tend to inhibit PDH kinase, thus activating
PDH. Further experiments showed that the second phase of PDH
activation by vasopressin could be explained by combined effects of an
increase in cytosolic ATP consumption, leading to a fall in [ATP]m, and
subsequent reoxidation of NAD(P)H, mediated by an increase in
respiratory chain activity. Vasopressin also induced an increase inΔψm
in the hepatocytes; this rise was more prolonged than changes in NAD
(P)H, reaching a peak value about 600 s.
Another mechanism operating in liver is that whereby hormones
that increase [Ca2+]c also cause an increase in mitochondrial matrix
volume, which signiﬁcantly affects respiration: Halestrap proposed
that the increase in volume involved a Ca2+-mediated increase in
pyrophosphate (PPi) in the mitochondrial matrix; PPi binding to the
adenine nucleotide translocase increases the permeability of K+
through this channel, and causes mitochondria to swell (for full
details see review by Halestrap [80]). This mechanism has been
demonstrated in response to vasopressin in hepatocytes [108] and
perfused liver [109], as well as in isolated mitochondria. Thus it could
play a complementary role to dehydrogenase activation by Ca2+ in
liver. However, in the heart, although increases in volume of isolated
mitochondria can stimulate respiration [110], this does not appear to
happen in vivo as changes in mitochondrial volume could not be
detected following perfusion of whole hearts with agonists that
increase [Ca2+]c [111].
4. Dysregulation in disease
For diseases of the liver and central nervous system please see
other reviews in this issue.
4.1. Heart
4.1.1. Ischaemia/reperfusion injury
[Ca2+]m has long been known to play a role in ischaemia/
reperfusion injury in the heart, especially in triggering the perme-
ability transition pore; this is discussed by Halestrap in this volume
and we will not consider it further here.
4.1.2. Cardiomyopathies
Hearts from cardiomyopathic hamsters develop heart failure, and
exhibit reduced developed pressure and adenine nucleotide content.
Perfusion with either pyruvate or isoproterenol restores both these
parameters [112]. In myocytes isolated from these hearts, there is a
reduction in PDH activity, and also a reduced [Ca2+]m in response to
rapid electrical stimulation compared with control hearts [113]. This
seemed likely due to a reduction in systolic Ca2+ transient, leading to
reduced [Ca2+]m and failure to activate PDH. Isolated mitochondria
also showed slightly reduced Ca2+ uptake (although only at higher
external Ca2+), indicating that a reduced [Ca2+]c may not be the only
mechanism — but these workers concluded that this was unlikely to
be physiologically relevant.
However, as discussed above, in other cell types mitochondria are
exposed to local high [Ca2+] domains near ER/SR release sites, and
this is likely to also be the case in cardiac myocytes [63]; a recent
paper therefore re-investigated mitochondrial Ca2+ transport in
mitochondria from the cardiomyopathic hamsters, with the assump-
tion that a reduction in transport at higher external [Ca2+] would be
physiologically relevant, and found that transport was reduced over a
range of [Ca2+] from 1–10 μM [114]. This was associated with a
reduced Δψm and reduced activities of complexes I and IV. It is
possible but untested that inhibiting the mNCX in these hearts would
be beneﬁcial in restoring [Ca2+]m and activating PDH.4.2. Complex I deﬁciency
An intriguing study looked at human mitochondrial complex I
deﬁciency — this is associated with numerous clinical symptoms,
ranging from lethal encephalopathy's, of which Leigh disease is the
most common, to neurodegenerative disorders, including Parkinson's
disease [115]. This study used skin ﬁbroblasts from children with
Complex I deﬁciency, and measured cytosolic Ca2+ transients in
response to bradykinin [116]. They found impaired increases in
[Ca2+]c, [Ca2+]m, and ATP production in response to bradykinin in the
complex I deﬁcient ﬁbroblasts. Treatment with 1 μM CGP37157, an
inhibitor ofmNCX that can be used in some cell types, restored all these
parameters.
They suggested that (i) decreased ATP production in this disease is
a result of reduced mitochondrial Ca2+ uptake, possibly due to a
reduced Δψm in these patients, and (ii) CGP37157 can indirectly
promote enhanced release of Ca2+ from the ER in these cells by
enhancing mitochondrial Ca2+ uptake so that there is less inhibitory
Ca2+ available at mouth of the IP3-operated ER Ca2+ release channels.
Complex I (NADH:ubiquinone oxidoreductase) deﬁciency is
associated with a range of progressive neurological disorders (early
onset and often devastating course). This group also found, using
ﬁbroblast lines derived from these patients, that [ATP]m, mitochon-
drial Ca2+ handling and ATP production are impaired to a variable
extent among these patients[117]. They concluded that reduction in
complex I activity leads to depolarisation of Δψm, decrease in ATP
supply to ATPases of intracellular stores (ER), and so to a reduced Ca2+
content of these stores. So less Ca2+ released in response to a stimulus,
so less [Ca2+]m accumulated and less ATP produced in response to that
stimulus.
5. Problems remaining
One question that remains unanswered due to lack of speciﬁc
inhibitors of the mitochondrial Ca2+ transporters is whether blocking
Ca2+ entry into mitochondria makes the heart unable to cope with
increased workload. One study addressed this using Ru360 in isolated
perfused rat hearts, and found it had no effect on contractile function
at b5 μM; above this concentration, contractile force generation was
depressed and resting tension elevated [118] — whether this was
attributed to mitochondrial or non-mitochondrial effects cannot be
determined from this study.
Thus it is difﬁcult to know whether inhibiting mitochondrial Ca2+
uptake in a normal beating heart has any detrimental effect, although
we can speculate that partial inhibition of mitochondrial Ca2+ uptake
achieved by low concentrations of Ru360 has no adverse effect,
whereas total inhibition, which would occur when using concentra-
tions N5 μM, depresses cardiac function. Even a partial inhibition of
CaUP may have a deleterious effect if the heart was stimulated with
adrenaline and/or subjected to increased workload, assuming that an
increase in [Ca2+]m under these conditions was essential for
increasing ATP supply. However, to the best of our knowledge, this
type of experiment has yet to be attempted.
Similarly although the studies above using CGP37157 are in theory
promising, this drug cannot be used in all cell types. We also do not
know what effect inhibition of mitochondrial Ca2+ efﬂux via the
mNCX or uptake via the CaUP would have on whole cell Ca2+
homeostasis.
6. Future directions
In theory it is now possible to measure [Ca2+]m in beating hearts
using genetically encoded probes, although no-one has yet done this.
Another leap forward would be provided by cloning of the
mitochondrial Ca2+ transporters, as well as development of more
speciﬁc inhibitors of the Ca2+ transport pathways. Although we have
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production, it is clear that other factors play a role under certain
conditions, notably the ATP/ADP ratio, and that the relative
importance will vary between tissues. Another current limitation is
that free [ADP] cannot be measured, and thus we do not really know
how free [ADP]c and [ADP]m are changing in vivo; measurements of
total [ADP] might give an indication of the direction of change, but it is
likely that more subtle but nevertheless important changes occur in
the concentration of this metabolite in different compartments.
Another emerging area is that of direct transfer of Ca2+ between the
SR and mitochondria in the heart, and it will be interesting to see
whether this provides a major source of increases in [Ca2+]m under
physiological conditions; so far this is suggested from experiments
using mitochondria isolated with attached SR components where
Ca2+ transfer from the SR-associated vesicle could increase NAD(P)H
[64]. Finally studies over the last few years have suggested that
stimulation of the citric acid cycle enzymes by increases in [Ca2+]m
during cardiac contraction may not be enough alone to provide the
necessary increases in respiration to meet cardiac energy demands
[76], and that ADP may after all be a major regulator of respiration via
the localised concentration gradients where mitochondria and
ATPases are organised into intracellular energy units [71,73]. However,
there is as yet no method for detecting local changes in ADP. Without
speciﬁc handles on the mitochondrial Ca2+ transporters it remains
impossible to unequivocally answer the question of whether they are
essential in the regulation of respiration in the heart and other tissues.
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